Paul D. Rubin, Senior VP Clinical Development & CMO at XOMA Corp (XOMA), sold 24,194 shares at $0.78 ($19K) on 2016-03-22, disclosed to the SEC on 2016-03-22.
Seasonal sale ($19k) by Senior VP Clinical Development & CMO — this insider has traded XOMA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| BIOA | SELL | 2026-02-03 | $139K | — | Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |